AtaiBeckley Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ATAI Nasdaq 2830 www.ataibeckley.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AtaiBeckley Inc.

Wall Street Analysts Predict a 31.48% Upside in AtaiBeckley Inc (ATAI): Here's What You Should Know - Aug 7th, 2026 7:55 am
Eli Lilly Stock: The One Question in Otherwise Perfect Earnings and What It Means for Shares - Aug 5th, 2026 11:43 am
LLY Q2 Earnings Top, GLP-1 Drugs Fuel Growth, Sales Guidance Raised - Aug 5th, 2026 10:07 am
Will Mounjaro & Zepbound Drive Lilly's Q2 Results: Buy, Sell or Hold? - Aug 3rd, 2026 9:17 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Aug 2nd, 2026 4:26 pm
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva - Jul 22nd, 2026 11:25 am
How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33% - Jul 22nd, 2026 7:55 am
Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout - Jul 17th, 2026 9:31 am
AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelics - Jul 17th, 2026 6:37 am
AtaiBeckley (ATAI) After Eli Lillys Bid Still Looks Fully Valued - Jul 17th, 2026 4:08 am
Eli Lilly's $3.8bn psychedelics bet is built on British science - Jul 17th, 2026 3:01 am
AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly - Jul 16th, 2026 6:19 pm
Eli Lilly Trips Into Red-Hot Psychedelics Space With A Big Takeover - Jul 16th, 2026 2:09 pm
AtaiBeckley Soars as Eli Lilly Agrees to $2.8 Billion Buyout - Jul 16th, 2026 12:59 pm